330 related articles for article (PubMed ID: 16428475)
21. Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function.
Wolk K; Mitsui H; Witte K; Gellrich S; Gulati N; Humme D; Witte E; Gonsior M; Beyer M; Kadin ME; Volk HD; Krueger JG; Sterry W; Sabat R
Clin Cancer Res; 2014 Nov; 20(21):5507-16. PubMed ID: 25212608
[TBL] [Abstract][Full Text] [Related]
22. Skin-homing CD8+ T lymphocytes show preferential growth in vitro and suppress CD4+ T-cell proliferation in patients with early stages of cutaneous T-cell lymphoma.
Thestrup-Pedersen K; Parhar R; Wu K; Bertilsson PA; Meyer B; Abu-Amero S; Hainau B; Aleisa A; Alfadley A; Hamadah I; Alajlan A; Al-Hussein K; Al-Mohanna F
Acta Derm Venereol; 2007; 87(2):118-26. PubMed ID: 17340017
[TBL] [Abstract][Full Text] [Related]
23. [Regulation of Th1 and Th2 immune responses by IL-18].
Nakanishi K
Kekkaku; 2002 Feb; 77(2):87-93. PubMed ID: 11905033
[TBL] [Abstract][Full Text] [Related]
24. Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas.
Sarris AH; Daliani D; Ulmer R; Crow M; Broxmeyer HE; Reiss M; Karasavvas N; Zelenetz AD; Pugh W; Cabanillas F; Deisseroth AB; Duvic M
Clin Cancer Res; 1997 Feb; 3(2):169-77. PubMed ID: 9815669
[TBL] [Abstract][Full Text] [Related]
25. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
Murakami T; Yamanaka K; Tokime K; Kurokawa I; Tsutsui H; Nakanishi K; Mizutani H
Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748
[TBL] [Abstract][Full Text] [Related]
26. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
Becker Y
Anticancer Res; 2006; 26(2A):1113-34. PubMed ID: 16619514
[TBL] [Abstract][Full Text] [Related]
27. Low herpesvirus entry mediator (HVEM) expression on dermal fibroblasts contributes to a Th2-dominant microenvironment in advanced cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Morimura S; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
J Invest Dermatol; 2012 Apr; 132(4):1280-9. PubMed ID: 22297640
[TBL] [Abstract][Full Text] [Related]
28. Correlation between phenotypic characteristics of mononuclear cells isolated from human periapical lesions and their in vitro production of Th1 and Th2 cytokines.
Colić M; Lukić A; Vucević D; Milosavljević P; Majstorović I; Marjanović M; Dimitrijević J
Arch Oral Biol; 2006 Dec; 51(12):1120-30. PubMed ID: 16797478
[TBL] [Abstract][Full Text] [Related]
29. Further support for a role for Th2-like cytokines in blister formation of pemphigus.
Caproni M; Giomi B; Cardinali C; Salvatore E; Pestelli E; D'Agata A; Bianchi B; Toto P; Feliciani C; Fabbri P
Clin Immunol; 2001 Feb; 98(2):264-71. PubMed ID: 11161984
[TBL] [Abstract][Full Text] [Related]
30. Activation of neutrophils in cutaneous T-cell lymphoma.
Goddard DS; Yamanaka K; Kupper TS; Jones DA
Clin Cancer Res; 2005 Dec; 11(23):8243-9. PubMed ID: 16322281
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous leishmaniasis in naturally infected dogs is associated with a T helper-2-biased immune response.
Brachelente C; Müller N; Doherr MG; Sattler U; Welle M
Vet Pathol; 2005 Mar; 42(2):166-75. PubMed ID: 15753470
[TBL] [Abstract][Full Text] [Related]
32. Eotaxins and CCR3 interaction regulates the Th2 environment of cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Fujita H; Ohmatsu H; Kakinuma T; Kadono T; Tamaki K; Sato S
J Invest Dermatol; 2010 Sep; 130(9):2304-11. PubMed ID: 20505746
[TBL] [Abstract][Full Text] [Related]
33. Expression of IL-19 correlates with Th2 cytokines in uraemic patients.
Hsing CH; Hsu CC; Chen WY; Chang LY; Hwang JC; Chang MS
Nephrol Dial Transplant; 2007 Aug; 22(8):2230-8. PubMed ID: 17449492
[TBL] [Abstract][Full Text] [Related]
34. Increased Interleukin-19 Expression in Cutaneous T-cell Lymphoma and Atopic Dermatitis.
Oka T; Sugaya M; Takahashi N; Nakajima R; Otobe S; Kabasawa M; Suga H; Miyagaki T; Asano Y; Sato S
Acta Derm Venereol; 2017 Nov; 97(10):1172-1177. PubMed ID: 28597022
[TBL] [Abstract][Full Text] [Related]
35. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J
J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593
[TBL] [Abstract][Full Text] [Related]
36. Interleukin (IL)-13 is the predominant Th2 cytokine in localized cutaneous leishmaniasis lesions and renders specific CD4+ T cells unresponsive to IL-12.
Bourreau E; Prévot G; Pradinaud R; Launois P
J Infect Dis; 2001 Mar; 183(6):953-9. PubMed ID: 11237813
[TBL] [Abstract][Full Text] [Related]
37. Human keratinocytes are major producers of IL-18: predominant expression of the unprocessed form.
Companjen AR; van der Velden VH; Vooys A; Debets R; Benner R; Prens EP
Eur Cytokine Netw; 2000 Sep; 11(3):383-90. PubMed ID: 11022122
[TBL] [Abstract][Full Text] [Related]
38. Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation.
Dummer R; Kohl O; Gillessen J; Kägi M; Burg G
Arch Dermatol; 1993 Apr; 129(4):433-6. PubMed ID: 8466213
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Th1-like, Th2-like and immunomodulatory cytokine mRNA expression in the skin of dogs with immunomodulatory-responsive lymphocytic-plasmacytic pododermatitis.
Breathnach RM; Fanning S; Mulcahy G; Bassett HF; Jones BR; Daly P
Vet Dermatol; 2006 Oct; 17(5):313-21. PubMed ID: 16961816
[TBL] [Abstract][Full Text] [Related]
40. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections.
Sindhu S; Toma E; Cordeiro P; Ahmad R; Morisset R; Menezes J
J Med Virol; 2006 Apr; 78(4):431-9. PubMed ID: 16482539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
